Fanyan Meng
Fudan University(CN)Anshun University(CN)First Affiliated Hospital of Liaoning Medical University(CN)Nanjing Drum Tower Hospital(CN)Jiangsu Cancer Hospital(CN)First Hospital of China Medical University(CN)State Key Laboratory of Genetic EngineeringNanjing University(CN)China Medical University(CN)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia(2020)1,191 cited
- → CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients(2016)302 cited
- → Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors(2019)224 cited
- → Forkhead Transcription Factor Foxq1 Promotes Epithelial–Mesenchymal Transition and Breast Cancer Metastasis(2011)179 cited
- → iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer(2019)123 cited
- → The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis(2012)118 cited